Synthesis and antimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties

References

• Shenai BR, Lee BJ, Hernandez AA, Chong PY, Emal CD, Neitz RJ, Roush WR, Rosenthal PJ. Structure-activity relationships for inhibition of cysteine protease activity and development of plasmodium falciparum by peptidyl vinyl sulfones. Antimicrob Agents Chemother 2003; 47: 154–160
   PubMed Web of Science ®Google Scholar
• Korolkovas A. Essentials of medicinal chemistry 19882nd ed. John Wiley & Sons, USA 1988; 647–649
   Google Scholar
• Krungkrai J, Scozzafava A, Reungprapavut S, Krungkrai SR, Rattanajak R, Kamchonwongpaisan S, Supuran CT. Carbonic anhydrase inhibitors. Inhibition of plasmodium falciparum carbonic anhydrase with aromatic sulfonamides towards antimalarials with a novel mechanism of action. Bioorg Med Chem 2005; 13: 483–489
   PubMed Web of Science ®Google Scholar
• Supuran CT, Scozzafava A, Casini A. Carbonic anhydrase inhibitors. Med Res Rev 2003; 23: 146–189
   PubMed Web of Science ®Google Scholar
• Clark WG, Brater DC, Johnson AR. Medical pharmacology13th ed. Mosby Year Book, USA 1992; 637
   Google Scholar
• Xia G, Li J, Peng A, Lai S, Zhang S, Shen J, Liu Z, Chen X, Ji R. Synthesis and phosphodiesterase 5 inhibitory activity of novel pyrido[1,2-e] purin-4(3H)-one derivatives. Bioorg Med Chem Lett 2005; 15: 2790–2794
   PubMed Web of Science ®Google Scholar
• Abbate F, Casini A, Owa T, Scozzafava A, Supuran CT. Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX. Bioorg Med Chem Lett 2004; 14: 217–223
   PubMed Web of Science ®Google Scholar
• Casini A, Scozzafava A, Mastrolorenzo A, Supuran CT. Sulfonamides and sulfonylated derivatives as anticancer agents. Curr Cancer Drug Targets 2002; 2: 55–75
   PubMed Web of Science ®Google Scholar
• Rahman A, Farghaly AH. Synthesis reactions and antimicrobial activity of some new indolyl-1,3,4- oxadiazole, triazole and pyrazole derivatives. J Chin Chem Soc 2004; 51: 147–156
   Web of Science ®Google Scholar
• Khanum SA, Shashikanth S, Umesha S, Kavitha R. Synthesis and antimicrobial study of novel heterocyclic compounds from hydroxybenzophenones. Eur J Med Chem 2005; 40: 1156–1162
   PubMed Web of Science ®Google Scholar
• Zheng X, Li Z, Wang Y, Chen W, Huang Q, Liu C, Song G. Synthesis and insecticidal activities of novel 2,5- disubstituted 1,3,4- oxadiazoles. J Fluorine Chem 2003; 117: 163–169
   Google Scholar
• Al-Soud YA, Al-Deeri MN, Al-Mosoudi NA. Synthesis, antitumor and antiviral properties of some 1,2,4- triazole derivatives. Il Farmaco 2004; 59: 775–783
   PubMedGoogle Scholar
• El-Emam AA, Al-Deeb OA, Al-Omar M Lehmann. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl) -2- substituted thio-1,3,4- oxadiazoles and 5-(1-adamantyl) -3- substituted aminomethyl -1,3,4- oxadiazoles -2-thiones. Bioorg Med Chem 2004; 12: 5107–5113
   PubMed Web of Science ®Google Scholar
• Hutt MP, ElLger EF, Werbel LM. 2-Phenyl-5-(trichloromethyl)-1,3,4- oxadiazoles, a new class of antimalarial substances. J Heterocycl Chem 1970; 7: 511–518
   Web of Science ®Google Scholar
• Neamati N, Mazumder A, Sunder S, Owen JM, Schultz RJ, Pommier Y. 2-Mercaptobenzenesulfonamides as a novel class of human immunodeficiency type 1 (HIV-1) integrase and HIV-1 replication. Antimicrob Agents Chemother 1997; 8: 485–495
   Google Scholar
• Louie AY, Meade TJ. Metal complexes as enzyme inhibitors. Chem Rev 1999; 99: 2711–2734
   PubMed Web of Science ®Google Scholar
• Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carrol SS, Pettibone DJ, Obrien JA, Ball RG, Ballani SK, Lin JH, Chen WI, Schleif WA, Sardana VV, Long WJ, Byrnes VW, Emini EA. L- 743,726 (DMP): A novel, highly potent, nonnucleoside inhibitor of human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 1995; 39: 2602–2605
   PubMed Web of Science ®Google Scholar
• Brzozowski Z, Saczewski F, Sanchez T, Kuo CL, Gdaniec M, Neamati N. Synthesis, antimicrobial, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2- benzodithiazines. Bioorg Med Chem 2004; 12: 5107–5113
   PubMed Web of Science ®Google Scholar
• Lai JYQ, Ferguson Y, Jones M. Preparation of substituted quinolinyl and isoquinolinyl sulfonyl chlorides for synthesis of novel sulfonamides. Synh Commun 2003; 33: 3427–3433
   Web of Science ®Google Scholar
• Furniss BS, Hannaford AJ, Rogers V, Smith PWG, Tatchell AR. Vogel textbook of practical organic chemistry4th ed. Longmann, London 1978, a: pp 1135; b: pp 505 c: pp 1242
   Google Scholar
• Yousif MY, Ismail AM, Elman AA, El-Kerdawy MM. Synthesis of substituted mercapto-1,2,4-triazoles and substituted 1,2,4-triazoles-5-ylmercaptomethyl-1,3,4-oxadiazoles as antimicrobal agents. J Chem Soc Pak 1986; 8: 183
   Web of Science ®Google Scholar
• Ahmad R, Iqbal R, Akhtar H, Haq ZU, Duddeck H, Stefaniak L, Sitkowski J. Synthesis and structure determination of some oxadiazole-2-thione and triazole-3-thione galactosides. Nucleosides, Nucleotides and Nucleic Acids 2001; 20: 1671–1682
   PubMed Web of Science ®Google Scholar
• Baelmans R, Deharo E, Muñoz V, Sauvain M, Ginsburg H. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin. Exp Parasitol 2000; 4: 243–248
   Google Scholar
• Mitsuya H, Weinhold KJ, Furman PA, St. Clair MH, Lehrmann SN, Gallo RC, Bolognesi D, Barry DW, Border S. 3′-Azido-3′-deoxythymidine (BW A509U): An antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985; 82: 7096–8000
   PubMed Web of Science ®Google Scholar
• Deharo E, Gautret Ph, Ginsburg H, Chabaud AG, Landau I. Synchronization of plasmodium yoelii nigeriensis and P.y. killicki infection in the mouse by means of percoll-glucose gradient stage fractionation: Determination of the duration of the schizogonic cycle. Parasitol Res 1994; 80: 159–164
   PubMed Web of Science ®Google Scholar
• Rosenthal P. Plasmodium falciparum: Effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp Parasitol 1995; 80: 272–281
   PubMed Web of Science ®Google Scholar
• Peters W. Chemotherapy and drug resistance in malaria2nd ed. Academic Press, New York 1987
   Google Scholar